Therapeutic outcome after resection of pulmonary @entity3 from XXXX .

@entity1 @entity135 @entity5 @entity3 @entity259
Hematogenous @entity3 is the most common form of @entity3 in @entity135 , and reports have described successful resection of pulmonary metastases of such @entity5 . We report treatment outcomes after surgical resection of pulmonary metastases of @entity135 and identify prognostic factors. This clinicopathologic study investigated the clinical records of 16 @entity1 with pulmonary metastases of @entity135 (excepting cases of @entity259 ) who had undergone metastasectomy at our center during the period 2001-2012. The mean age of the 16 @entity1 (11 @entity1 and 5 @entity1 ) was 62.1  years. The mean interval between completion of successful treatment of the @entity5 and detection of pulmonary @entity3 was 21  months (range, 6-56  months). All @entity1 underwent pulmonary resection. The overall 1-year survival rate was 79.4  %, and the 2- to 5-year survival rate was 63.2  %. These rates compare favorably to those in previous reports on resection of pulmonary metastases. When prognostic factors for survival rates were compared, the factors associated with a negative prognosis were a disease-free interval of <12  months and partial resection of pulmonary metastases. Multivariate analysis did not reveal any prognostic factors associated with negative outcomes. Surgical resection of pulmonary metastases of @entity135 might improve outcomes.
